TUCSON, Ariz., June 28, 2011 /PRNewswire/ -- The PleuraFlow™ Active Tube Clearance™ System has been recognized as one of the winners of the 49th Annual R&D 100 Awards, which salute the 100 most technologically significant products introduced into the marketplace over the past year. A full list of this year's winners is available at www.rdmag.com. This award comes on the heels of winning a 2011 MDEA Gold award, as well as ID Design Distinction recognition and the European Association of Cardiothoracic Surgeons (EACTS) Techno Innovation awards.
As the first chest tube with a mechanism for actively clearing blood clots, the PleuraFlow Active Tube Clearance System represents the most significant innovation in chest tubes in half a century. The PleuraFlow Active Tube Clearance System incorporates a metal loop at the end of a guide wire inside the tube. A guide sleeve outside the tube is connected via magnetic coupling to the guide wire. Clots can be cleared, without breaking the sterile field, by shuttling the guide sleeve back and forth along the tube. The device was designed and developed by Clear Catheter Systems and Carbon Design Group. Xeridiem designed and developed the manufacturing process as well as manages logistics including order fulfillment.
"The PleuraFlow Active Tube Clearance System is being used in the US, EU, and Canada to help patients recover from heart surgery safely and comfortably. We appreciate the contribution from Carbon and Xeridiem to help us bring this product to market," said Edward Boyle, the CEO of Clear Catheter Systems.
"This award demonstrates our ability to work closely with medical innovators to bring novel products to market quickly, effectively, and on budget," said Joseph Lee, Xeridiem's President.
The R&D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics, software, manu
|SOURCE Xeridiem Medical Devices, Inc.|
Copyright©2010 PR Newswire.
All rights reserved